User contributions

From OncoWiki
Jump to: navigation, search
Search for contributions
 
 
     
  

(newest | oldest) View ( | older 50) (20 | 50 | 100 | 250 | 500)

  • 12:01, 6 August 2007 (diff | hist) . . (+567). . N CLAG(New page: == Indication == Relapsed or refractory acute myeloid leukemia == Regimen == *Cladribine 5 mg/m2/d iv over 2 hrs d1-5 *Cytarabine (Ara-C) 2 g/m2/d iv over 4 hrs d1-5 *Filgrastim (Neupogen...)
  • 11:59, 6 August 2007 (diff | hist) . . (+520). . Nm Acute Myeloid Leukemia,Adult(Salvage Regimens)
  • 11:58, 6 August 2007 (diff | hist) . . (+957). . Nm Gemtuzumab Ozogamicin
  • 09:30, 6 August 2007 (diff | hist) . . (+2,650). . N Total Therapy 2(New page: == Multiple Myeloma == === Induction === * Cycle 1, VAD Vincristine (0.5 mg/d x 4 d) CI; Adriamycin (10 mg/m2/d x 4 d) CI; Dexamethasone 40 mg PO d 1-4, 9-12, 17-20 * Cycle 2, DCE...)
  • 09:15, 6 August 2007 (diff | hist) . . (+1,271). . N Total Therapy 1(New page: == Multiple Myeloma == === Induction phase === *Cycles 1-3, VAD Vincristine (0.5 mg/d x 4 d) CI; Adriamycin (10 mg/m2/d x 4 d) CI; Dexamethasone 40 mg PO d 1-4, 9-12, 17-20 *Cycle 4...)
  • 08:57, 6 August 2007 (diff | hist) . . (+555). . Nm VMPT
  • 08:53, 6 August 2007 (diff | hist) . . (+1,374). . N Rev/Dex(New page: == Multiple Myeloma == === Rev/Dex low dose === Lenalidomide (Revlimid) 25 mg po qd d1-21<br> Dexamethasone (Decadron) 40 mg po d1, 8, 15, 22<br> Q4w ==== References ==== [http://www.asc...)
  • 08:50, 6 August 2007 (diff | hist) . . (+454). . N DVD(New page: == Multiple Myeloma == Pegylated liposomal doxorubicin (Doxil) 40 mg/m2 iv d1<br> Vincristine 2 mg iv d1<br> Dexamethasone (Decadron) 40 mg po qd d1-4<br> Q4w === References === [http://...)
  • 08:48, 6 August 2007 (diff | hist) . . (+487). . N VAD(New page: == Multiple Myeloma == Vincristine 0.4 mg iv over 30 min qd d1-4<br> Doxorubicin (Adriamycin) 9 mg/m2 iv over 30 min qd d1-4<br> Dexamethasone (Decadron) 40 mg po qd d1-4, 9-12, 17-20<br>...)
  • 08:46, 6 August 2007 (diff | hist) . . (+1,215). . N MPT(New page: == Multiple Myeloma == === Melphalan + Prednisone + Thalidomide regimen 1 === Melphalan (Alkeran) 0.25 mg/kg/d po d1-4 q6w x 12 cycles<br> Prednisone 2 mg/kg/d po d1-4 q6w x 12 cycles<br> ...)
  • 08:43, 6 August 2007 (diff | hist) . . (+2,063). . N Thal/Dex(New page: == Multiple Myeloma == Thalidomide ((Thalomid) 100-200 mg po qd<br> Dexamethasone (Decadron) 40 mg po qd d1-4, 9-12, 17-20 for odd cycles and d1-4 only for even cycles q4w Thal-Dex was p...)
  • 08:34, 6 August 2007 (diff | hist) . . (+680). . Nm MP
  • 05:03, 6 August 2007 (diff | hist) . . (+643). . Nm Hematological Malignancies
  • 23:49, 5 August 2007 (diff | hist) . . (+962). . N FC
  • 23:11, 5 August 2007 (diff | hist) . . (+94). . N Chronic Myelogenous Leukemia(New page: == Single agents == Imatinib (Gleevec) Dasatinib (Sprycel) Nilotinib (Tasigna))
  • 14:59, 5 August 2007 (diff | hist) . . (+5,929). . N BFM- 95 (German Protocol)(Regimen)
  • 14:54, 5 August 2007 (diff | hist) . . (+1,536). . Nm Arsenic Trioxide for relapsed APML
  • 14:48, 5 August 2007 (diff | hist) . . (+643). . N 5-FU MitomycinC Radiation Therapy EORTC Regimen(New page: == Regimen == * 5-Flurouracil: 750mg/m2/day IV continuous infusion on days 1-5 and 29-33 * Mitomycin-C: 15mg/m2 IV on day 1 * Radiation therapy: 180 cGy/day over 5 week period (tota...)
  • 14:43, 5 August 2007 (diff | hist) . . (+430). . N 5-FU MitomycinC Radiation Therapy Wayne State Regimen(New page: == Regimen == * 5-Fluorouracil 1000mg/m2/day continuous infusion on days 1-4 and 29-32 * Mitomycin-C 15mg/m2 IV on day 1 * Radiation therapy: 200cGy/day on days 1-5, 8-12, and 5-19 (...)
  • 14:42, 5 August 2007 (diff | hist) . . (+381). . N Anal Carcinoma
  • 14:00, 5 August 2007 (diff | hist) . . (+2,879). . N EAPLG(New page: == Regimen == === Age < 60 and WBC < 10,000/uL === ==== Induction therapy ==== All trans retinoic acid (ATRA) 45 mg/m2 po qd in 2 divided doses d1 till hematologic CR<br> Cytarabine (Ara-...)
  • 13:52, 5 August 2007 (diff | hist) . . (+2,080). . N CALGB 9710(New page: == Regimen == === Induction therapy === All trans retinoic avid (ATRA) 45 mg/m2 po qd in 2 divided doses d1 till hematologic CR<br> Cytarabine (Ara-C) 200 mg/m2/d civi d3-9<br> Daunorubic...)
  • 13:41, 5 August 2007 (diff | hist) . . (+1,574). . N Arsenic Trioxide for APML, new cases(New page: == Regimen == === Intravenous arsenic trioxide === Arsenic trioxide was administered by diluting 10 mg/10 ml vials in 500 ml of Dextrose saline for adults infusing it intravenously over 2...)
  • 13:38, 5 August 2007 (diff | hist) . . (+3,581). . N AIDA-PETHEMA Group(New page: == Regimen == === Induction therapy === Oral ATRA (45 mg/m2/d), divided into 2 daily doses, until complete hematologic remission, or for a maximum of 90 days<BR> Idarubicin (12 mg/m2/d) ...)
  • 13:34, 5 August 2007 (diff | hist) . . (+727). . N ATRA plus As203(New page: == Regimen == All patients received 25mg/m2 ATRA orally and 0.16mg/kg As2O3 intravenously per day till CR. <BR> Once CR achieved, they were given 3 courses of consolidation chemotherapy a...)
  • 13:33, 5 August 2007 (diff | hist) . . (+1,718). . N Postremission High Dose Cytarabine(New page: == Regimen == Cytarabine 3 g per square meter 3-hour infusion every 12 hours (twice daily) on days 1, 3, and 5 for a total of six doses per course Sequential courses no sooner than every...)
  • 13:30, 5 August 2007 (diff | hist) . . (+1,023). . N FLAG-Ida(New page: == Regimen == Fludarabine 30 mg/m2 intravenous (i.v.) infusion for 30 min on days 1 to 5 Ara-C 2 g/m2 i.v. infusion (started 4 h after the start of the Fludarabine) for 2 h on days 1 ...)
  • 13:27, 5 August 2007 (diff | hist) . . (+515). . N FLAG(New page: == Regimen == Fludarabine 30 mg/m2 IV (30 min) days 1-5<BR> Cytarabine 2000 mg/m2 IV days 1-5 (3.5 hours after fludarabine)<BR> G-CSF 300 mcg sc until hematopoietic recovery<BR> == Refer...)
  • 13:26, 5 August 2007 (diff | hist) . . (+801). . N HAM(New page: == Regimen == Cytarabine 3000 mg/m2 bd IVI (3 hr) days 1-3<BR> Mitoxantrone 10 mg/m2 IVI (30 min) days 3-5<BR> == References == [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retriev...)
  • 13:25, 5 August 2007 (diff | hist) . . (+414). . N ICE-aml(New page: == Regimen == Idarubicin 10 mg/m2 IV days 1,3,5<BR> Cytarabine 100 mg/m2 CI days 1-10<BR> Etoposide 100 mg/m2 IV days 1-5<BR> == References == [http://www.ncbi.nlm.nih.gov/entrez/query.f...)
  • 13:25, 5 August 2007 (diff | hist) . . (+469). . N ADE(New page: == Regimen == Ara-C 100 mg/m2 12 hourly IV push Days 1-10<BR> Daunorubicin 50 mg/m2 IV push Days 1, 3, 5<BR> Etoposide 100 mg/m2/day 1 hour infusion Days 1-5<BR> == References == [http:/...)
  • 13:23, 5 August 2007 (diff | hist) . . (+465). . N DAT(New page: == Regimen == Daunorubicin 50 mg/m2 IV push Days 1, 3, 5<BR> Ara-C 100 mg/m2 12 hourly IV push Days 1-10<BR> Thioguanine 100 mg/m2 12 hourly PO Days 1-10<BR> == References == [http://www...)
  • 13:22, 5 August 2007 (diff | hist) . . (+1,216). . N Standard3plus7(New page: == Regimens == === Variation 1 === Daunorubicin 45-60 mg/m2 IV on days 1-3<BR> Cytarabine 100 mg/m2 CIV on days 1-7 === Variation 2 === Idarubicin 12 mg/m2 IV slow bolus Days 1-3<BR> Ara...)
  • 11:47, 5 August 2007 (diff | hist) . . (+1,930). . N CALGB 9111(New page: == Regimen == Cycle 1 (4 wks) Cyclophosphamide (Cytoxan) 1200 mg/m2 iv d1 Doxorubicin (Adriamycin) 45 mg/m2/d iv d1, 2, 3 Vincristine 2 mg iv d1, 8, 15, 22 Prednisone 60 mg/m2 po or ...)
  • 11:41, 5 August 2007 (diff | hist) . . (+593). . N R-FCM + maintenance R(New page: == Regimen == R-FCM followed by Rituximab 375 mg/m2 iv qw x 4 doses at 3 and 9 months == References == [http://www.bloodjournal.org/cgi/content/abstract/108/13/4003 Forstpointner R e...)
  • 11:31, 5 August 2007 (diff | hist) . . (+951). . N RTOG study 93-10(New page: == Regimen == Methotrexate 2500 mg/m2 iv(2-3 h inf) day 1, every other week x 5 (week 1,3,5,7,9)<BR> Folinic acid 20mg p.o. Every 6 h for 12 doses (week 1,3,5,7,9)<BR> Vincristine 1.4 mg/m...)
  • 11:29, 5 August 2007 (diff | hist) . . (+696). . N M-BACOD(New page: == Regimen == Methotrexate 200 mg/m2 IV on days 8 and 15<BR> Leucoverin 10 mg/m2 PO every 6 hours for 8 doses beginning 24 hours after methotrexate<BR> Bleomycin 4 u/m2 IV on day 1<BR> Dox...)
  • 11:28, 5 August 2007 (diff | hist) . . (+817). . N MINE/ESHAP(New page: == Regimen == === MINE === Ifosfamide 1333 mg/m2 IV (1 hr) days 1-3<BR> with Mesna<BR> Mitoxantrone 8 mg/m2 IV (15 min) day 1<BR> Etoposide 65 mg/m2 IV (1 hr) days 1-3<BR> To be repeated...)
  • 11:27, 5 August 2007 (diff | hist) . . (+1,304). . N VNCOP-B(New page: == Regimen == Cyclophosphamide 300 mg/m2 IV Weeks 1, 3, 5, 7 Mitoxantrone 10 mg/m2 IV Weeks 1, 3, 5, 7 Vincristine 2 mg IV Weeks 2, 4, 6, 8 Etoposide 150 mg/m2 IV Weeks 2, 6 Bleomyci...)
  • 11:25, 5 August 2007 (diff | hist) . . (+771). . N MACOP-B(New page: == Regimen == Methotrexate 400 mg/m2 IV on weeks 2,6 and 10<BR> Leucovorin 15 mg/m2 PO every 6 hours for 6 doses, beginning 24 hours after methotrexate<BR> Doxorubicin 50 mg/m2 IV on weeks...)
  • 11:24, 5 August 2007 (diff | hist) . . (+1,101). . N RICE(New page: == Regimen == Cycle 1 Rituximab 375 mg/m2/day IV day -2 Rituximab 375 mg/m2/day IV day 1 Etoposide 100 mg/m2/day IV days 3-5 Carboplatin 5 x (25 + Cr clearance), capped at 800...)
  • 11:08, 5 August 2007 (diff | hist) . . (+731). . N ICE(New page: == Regimen == Ifosfamide 5,000 mg/m2 IV continuous infusion for 24 hours on day 2<BR> Mesna 5,000 mg/m2 IV in combination with Ifosfamide dose<BR> Carboplatin AUC 5 (5 x (25 + creatinine c...)
  • 09:23, 5 August 2007 (diff | hist) . . (+650). . N EPIC(New page: == Regimen == Etoposide 100 mg/m2 IV (I h infusion) Days 1-4 Prednisolone 100 mg/2 PO Days 1-5 Ifosfamide 1 g/m2 IV (15 min infusion) Days 1-5 (with mesna) Carboplatin 240 mg/m2 IV (...)
  • 09:21, 5 August 2007 (diff | hist) . . (+1,900). . N EBVMm(New page: == Regimen == Epirubicin 30 mg/m2 IV Days 1, 15 Bleomycin 10 mg/m2 IV Days 1, 15 Vinblastine 6 mg/m2 IV Days 1, 15 Methotrexate 30 mg/m2 IV Days 1, 15 Methylprednisolone 120 mg/m2 IV...)
  • 09:18, 5 August 2007 (diff | hist) . . (+797). . N COPP(New page: == Regimen == Cyclophosphamide 650mg/m2 IVB day 1,8<BR> Vincristine 1.4 mg/m2 IVB day 1,8<BR> Procarbazine 100mg/m2 PO day 1-14<BR> Prednisolone 40mg/m2 PO day 1-14<BR> Cycle q21-28 days ...)
  • 09:17, 5 August 2007 (diff | hist) . . (+451). . Nm ChlVPP(References)
  • 09:15, 5 August 2007 (diff | hist) . . (+515). . N CEP(New page: == Indication == Relapsed, refractory HD == Regimen == CCNU 80mg/m2 PO day 1 <BR> Etoposide 100mg/m2 PO days 1-5 <BR> Prednimustine 60mg/m2 days 1-5 For relapses from MOPP/ABVD less than...)
  • 09:12, 5 August 2007 (diff | hist) . . (+805). . Nm ASHAP
  • 09:05, 5 August 2007 (diff | hist) . . (+527). . Nm ABVD(References)
  • 09:01, 5 August 2007 (diff | hist) . . (+3,886). . Nm MRC UKALL XII/ECOG E2993(CNS prophylaxis)

(newest | oldest) View ( | older 50) (20 | 50 | 100 | 250 | 500)